Peptidomimetic protease inhibitors

Peptidomimetic Protease Inhibitors Abstract The present invention relates to peptidomimetic compounds useful as protease inhibitors (1), particularly as serine protease inhibitors and more particularly as hepatitis 5 C NS3 protease inhibitors; intermediates thereto; their preparation including novel...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: GARCIA-PAREDES, CRISTINA, SNYDER, NANCY JUNE, LAMAR, JASON ERIC, SUN, XICHENG DAVID, WANG, Q. MAY, YIP, YVONNE YEE MAI, GLASS, JOHN IRVIN, COLLADO, IVAN, TEBBE, MARK JOSEPH, BABINE, ROBERT EDWARD, CHEN, SHU HUI, PARKER III, RAYMOND SAMUEL, GUO, DEQI, JIN, LING, VICTOR, FRANTZ
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator GARCIA-PAREDES, CRISTINA
SNYDER, NANCY JUNE
LAMAR, JASON ERIC
SUN, XICHENG DAVID
WANG, Q. MAY
YIP, YVONNE YEE MAI
GLASS, JOHN IRVIN
COLLADO, IVAN
TEBBE, MARK JOSEPH
BABINE, ROBERT EDWARD
CHEN, SHU HUI
PARKER III, RAYMOND SAMUEL
GUO, DEQI
JIN, LING
VICTOR, FRANTZ
description Peptidomimetic Protease Inhibitors Abstract The present invention relates to peptidomimetic compounds useful as protease inhibitors (1), particularly as serine protease inhibitors and more particularly as hepatitis 5 C NS3 protease inhibitors; intermediates thereto; their preparation including novel steroselective processes to intermediates. The invention is also directed to pharmaceutical compositions and to methods for using the compounds for inhibiting HCV protease or treating a patient suffering from an HCV infection or physiological condition related to the infection. Also provided are pharmaceutical combinations comprising, in 1o addition to one or more HCV seine protease inhibitors, one or more interferons exhibiting anti-HCV activity and/or one or more compounds having anti HCV activity and a pharmaceutically acceptable carrier, and methods for treating or preventing a HCV infection in a patient using the compositions. The present invention is also directed to a kit or pharmaceutical pack for treating or preventing HCV infection in a patient.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_AU2007240156CC1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>AU2007240156CC1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_AU2007240156CC13</originalsourceid><addsrcrecordid>eNrjZFAKSC0oyUzJz83MTS3JTFYoKMovSU0sTlXIzMvITMosyS8q5mFgTUvMKU7lhdLcDCpuriHOHrqpBfnxqcUFicmpeakl8Y6hRgYG5kYmBoamZs7OhsZEKgMA2Mgn9g</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Peptidomimetic protease inhibitors</title><source>esp@cenet</source><creator>GARCIA-PAREDES, CRISTINA ; SNYDER, NANCY JUNE ; LAMAR, JASON ERIC ; SUN, XICHENG DAVID ; WANG, Q. MAY ; YIP, YVONNE YEE MAI ; GLASS, JOHN IRVIN ; COLLADO, IVAN ; TEBBE, MARK JOSEPH ; BABINE, ROBERT EDWARD ; CHEN, SHU HUI ; PARKER III, RAYMOND SAMUEL ; GUO, DEQI ; JIN, LING ; VICTOR, FRANTZ</creator><creatorcontrib>GARCIA-PAREDES, CRISTINA ; SNYDER, NANCY JUNE ; LAMAR, JASON ERIC ; SUN, XICHENG DAVID ; WANG, Q. MAY ; YIP, YVONNE YEE MAI ; GLASS, JOHN IRVIN ; COLLADO, IVAN ; TEBBE, MARK JOSEPH ; BABINE, ROBERT EDWARD ; CHEN, SHU HUI ; PARKER III, RAYMOND SAMUEL ; GUO, DEQI ; JIN, LING ; VICTOR, FRANTZ</creatorcontrib><description>Peptidomimetic Protease Inhibitors Abstract The present invention relates to peptidomimetic compounds useful as protease inhibitors (1), particularly as serine protease inhibitors and more particularly as hepatitis 5 C NS3 protease inhibitors; intermediates thereto; their preparation including novel steroselective processes to intermediates. The invention is also directed to pharmaceutical compositions and to methods for using the compounds for inhibiting HCV protease or treating a patient suffering from an HCV infection or physiological condition related to the infection. Also provided are pharmaceutical combinations comprising, in 1o addition to one or more HCV seine protease inhibitors, one or more interferons exhibiting anti-HCV activity and/or one or more compounds having anti HCV activity and a pharmaceutically acceptable carrier, and methods for treating or preventing a HCV infection in a patient using the compositions. The present invention is also directed to a kit or pharmaceutical pack for treating or preventing HCV infection in a patient.</description><language>eng</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; ENZYMOLOGY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>2014</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20140116&amp;DB=EPODOC&amp;CC=AU&amp;NR=2007240156C1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20140116&amp;DB=EPODOC&amp;CC=AU&amp;NR=2007240156C1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>GARCIA-PAREDES, CRISTINA</creatorcontrib><creatorcontrib>SNYDER, NANCY JUNE</creatorcontrib><creatorcontrib>LAMAR, JASON ERIC</creatorcontrib><creatorcontrib>SUN, XICHENG DAVID</creatorcontrib><creatorcontrib>WANG, Q. MAY</creatorcontrib><creatorcontrib>YIP, YVONNE YEE MAI</creatorcontrib><creatorcontrib>GLASS, JOHN IRVIN</creatorcontrib><creatorcontrib>COLLADO, IVAN</creatorcontrib><creatorcontrib>TEBBE, MARK JOSEPH</creatorcontrib><creatorcontrib>BABINE, ROBERT EDWARD</creatorcontrib><creatorcontrib>CHEN, SHU HUI</creatorcontrib><creatorcontrib>PARKER III, RAYMOND SAMUEL</creatorcontrib><creatorcontrib>GUO, DEQI</creatorcontrib><creatorcontrib>JIN, LING</creatorcontrib><creatorcontrib>VICTOR, FRANTZ</creatorcontrib><title>Peptidomimetic protease inhibitors</title><description>Peptidomimetic Protease Inhibitors Abstract The present invention relates to peptidomimetic compounds useful as protease inhibitors (1), particularly as serine protease inhibitors and more particularly as hepatitis 5 C NS3 protease inhibitors; intermediates thereto; their preparation including novel steroselective processes to intermediates. The invention is also directed to pharmaceutical compositions and to methods for using the compounds for inhibiting HCV protease or treating a patient suffering from an HCV infection or physiological condition related to the infection. Also provided are pharmaceutical combinations comprising, in 1o addition to one or more HCV seine protease inhibitors, one or more interferons exhibiting anti-HCV activity and/or one or more compounds having anti HCV activity and a pharmaceutically acceptable carrier, and methods for treating or preventing a HCV infection in a patient using the compositions. The present invention is also directed to a kit or pharmaceutical pack for treating or preventing HCV infection in a patient.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2014</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZFAKSC0oyUzJz83MTS3JTFYoKMovSU0sTlXIzMvITMosyS8q5mFgTUvMKU7lhdLcDCpuriHOHrqpBfnxqcUFicmpeakl8Y6hRgYG5kYmBoamZs7OhsZEKgMA2Mgn9g</recordid><startdate>20140116</startdate><enddate>20140116</enddate><creator>GARCIA-PAREDES, CRISTINA</creator><creator>SNYDER, NANCY JUNE</creator><creator>LAMAR, JASON ERIC</creator><creator>SUN, XICHENG DAVID</creator><creator>WANG, Q. MAY</creator><creator>YIP, YVONNE YEE MAI</creator><creator>GLASS, JOHN IRVIN</creator><creator>COLLADO, IVAN</creator><creator>TEBBE, MARK JOSEPH</creator><creator>BABINE, ROBERT EDWARD</creator><creator>CHEN, SHU HUI</creator><creator>PARKER III, RAYMOND SAMUEL</creator><creator>GUO, DEQI</creator><creator>JIN, LING</creator><creator>VICTOR, FRANTZ</creator><scope>EVB</scope></search><sort><creationdate>20140116</creationdate><title>Peptidomimetic protease inhibitors</title><author>GARCIA-PAREDES, CRISTINA ; SNYDER, NANCY JUNE ; LAMAR, JASON ERIC ; SUN, XICHENG DAVID ; WANG, Q. MAY ; YIP, YVONNE YEE MAI ; GLASS, JOHN IRVIN ; COLLADO, IVAN ; TEBBE, MARK JOSEPH ; BABINE, ROBERT EDWARD ; CHEN, SHU HUI ; PARKER III, RAYMOND SAMUEL ; GUO, DEQI ; JIN, LING ; VICTOR, FRANTZ</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_AU2007240156CC13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2014</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>GARCIA-PAREDES, CRISTINA</creatorcontrib><creatorcontrib>SNYDER, NANCY JUNE</creatorcontrib><creatorcontrib>LAMAR, JASON ERIC</creatorcontrib><creatorcontrib>SUN, XICHENG DAVID</creatorcontrib><creatorcontrib>WANG, Q. MAY</creatorcontrib><creatorcontrib>YIP, YVONNE YEE MAI</creatorcontrib><creatorcontrib>GLASS, JOHN IRVIN</creatorcontrib><creatorcontrib>COLLADO, IVAN</creatorcontrib><creatorcontrib>TEBBE, MARK JOSEPH</creatorcontrib><creatorcontrib>BABINE, ROBERT EDWARD</creatorcontrib><creatorcontrib>CHEN, SHU HUI</creatorcontrib><creatorcontrib>PARKER III, RAYMOND SAMUEL</creatorcontrib><creatorcontrib>GUO, DEQI</creatorcontrib><creatorcontrib>JIN, LING</creatorcontrib><creatorcontrib>VICTOR, FRANTZ</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>GARCIA-PAREDES, CRISTINA</au><au>SNYDER, NANCY JUNE</au><au>LAMAR, JASON ERIC</au><au>SUN, XICHENG DAVID</au><au>WANG, Q. MAY</au><au>YIP, YVONNE YEE MAI</au><au>GLASS, JOHN IRVIN</au><au>COLLADO, IVAN</au><au>TEBBE, MARK JOSEPH</au><au>BABINE, ROBERT EDWARD</au><au>CHEN, SHU HUI</au><au>PARKER III, RAYMOND SAMUEL</au><au>GUO, DEQI</au><au>JIN, LING</au><au>VICTOR, FRANTZ</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Peptidomimetic protease inhibitors</title><date>2014-01-16</date><risdate>2014</risdate><abstract>Peptidomimetic Protease Inhibitors Abstract The present invention relates to peptidomimetic compounds useful as protease inhibitors (1), particularly as serine protease inhibitors and more particularly as hepatitis 5 C NS3 protease inhibitors; intermediates thereto; their preparation including novel steroselective processes to intermediates. The invention is also directed to pharmaceutical compositions and to methods for using the compounds for inhibiting HCV protease or treating a patient suffering from an HCV infection or physiological condition related to the infection. Also provided are pharmaceutical combinations comprising, in 1o addition to one or more HCV seine protease inhibitors, one or more interferons exhibiting anti-HCV activity and/or one or more compounds having anti HCV activity and a pharmaceutically acceptable carrier, and methods for treating or preventing a HCV infection in a patient using the compositions. The present invention is also directed to a kit or pharmaceutical pack for treating or preventing HCV infection in a patient.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_AU2007240156CC1
source esp@cenet
subjects BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SPIRITS
VINEGAR
WINE
title Peptidomimetic protease inhibitors
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T14%3A36%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=GARCIA-PAREDES,%20CRISTINA&rft.date=2014-01-16&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EAU2007240156CC1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true